Wall Street Analysts Think Insmed (INSM) Could Surge 33.6%: Read This Before Placing a Bet

Insmed (INSM) closed the last trading session at $161, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $215.1 indicates a 33.6% upside potential.The average comprises 20 short-term price targets ranging from a low of $162.00 to a high of $241.00, with a standard deviation of $19.56. While the lowest estimate indicates an increase of 0.6% from the current price level, t ...